DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease
NCT04420598
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
41
Enrollment
OTHER
Sponsor class
Conditions
Advanced Breast Cancer
HER2-positive Breast Cancer
Brain Metastases
Leptomeningeal Metastasis
Interventions
DRUG:
Trastuzumab deruxtecan
Sponsor
MedSIR
Collaborators
[object Object]